Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase I/II study of paclitaxel in combination with amifostine and twice daily radiotherapy for advanced head and neck cancer

Phase I/II study of paclitaxel in combination with amifostine and twice daily radiotherapy for advanced head and neck cancer. Sixth Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer. 2002; (#084).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.